{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:31:00Z","timestamp":1780515060225,"version":"3.54.1"},"reference-count":23,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,12]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Cytokine receptor\u2013like factor 2 rearrangement (CRLF2r), an aberration causing a Philadelphia chromosome\u2013like gene expression profile and a poor prognostic marker in B-cell acute lymphoblastic leukemia (B-ALL), endows relative chemotherapeutic resistance. Extramedullary disease (EMD), including both central nervous system (CNS) and non-CNS involvement, can also be associated with worse outcomes. The relationship between CRLF2r and EMD is unknown. Based on an initial observation of patients with relapsed\/refractory (R\/R) CRLF2r B-ALL and EMD, a single-center retrospective review was conducted to evaluate the incidence of EMD in patients with CRLF2r B-ALL. Across 177 children, adolescents, and young adults with R\/R B-ALL, 21 (11.9%) harbored CRLF2r, of whom 19 (90.5%) had EMD at some point during their treatment course. In contrast, only 78 of the 156 patients (50%) without CRLF2r ever had EMD (P = .0003). In the CRLF2r cohort, 8 (38.1%) presented with EMD at diagnosis: 7 with CNS and 1 with non-CNS EMD. At relapse, 17 (80.9%) had EMD: 4 (19%) had CNS EMD, 9 (42.9%) had non-CNS EMD, and 4 (19%) had both. Isolated EMD was observed in 2 patients (11.8%) at first relapse and in 3 (17.6%) with multiple relapses. Given these findings, further study to evaluate this potential association between EMD and CRLF2r in R\/R B-ALL is indicated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018480","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T20:54:06Z","timestamp":1771448046000},"page":"3044-3053","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["<i>CRLF2<\/i>\n                    rearrangement and extramedullary disease in B-cell acute lymphoblastic leukemia: a possible link?"],"prefix":"10.1182","volume":"10","author":[{"given":"Flavia","family":"Gava","sequence":"first","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Yates","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoxin","family":"Sun","sequence":"additional","affiliation":[{"name":"2Dana Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Li","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"O\u2019Koren","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"},{"name":"3Department of Pediatric Oncology, Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7773-9792","authenticated-orcid":false,"given":"Biplov","family":"Adhikari","sequence":"additional","affiliation":[{"name":"4National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Lugar","sequence":"additional","affiliation":[{"name":"5Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haneen","family":"Shalabi","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Mattison","sequence":"additional","affiliation":[{"name":"6Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5216-3528","authenticated-orcid":false,"given":"Evrim B.","family":"Turkbey","sequence":"additional","affiliation":[{"name":"7Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2601-3665","authenticated-orcid":false,"given":"Constance M.","family":"Yuan","sequence":"additional","affiliation":[{"name":"8Laboratory of Pathology, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Paietta","sequence":"additional","affiliation":[{"name":"9Montefiore Medical Center, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5408-9253","authenticated-orcid":false,"given":"Hao-Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"8Laboratory of Pathology, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-1850","authenticated-orcid":false,"given":"Charles","family":"Mullighan","sequence":"additional","affiliation":[{"name":"10St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara K.","family":"Silbert","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9816-6302","authenticated-orcid":false,"given":"Mark","family":"Litzow","sequence":"additional","affiliation":[{"name":"11Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8474-9080","authenticated-orcid":false,"given":"Nirali N.","family":"Shah","sequence":"additional","affiliation":[{"name":"1Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"19","key":"2026051211563292800_bib1","doi-asserted-by":"crossref","first-page":"7347","DOI":"10.1158\/0008-5472.CAN-10-1528","article-title":"CRLF2 and JAK2 in B-progenitor acute lymphoblastic leukemia: a novel association in oncogenesis","volume":"70","author":"Roll","year":"2010","journal-title":"Cancer Res"},{"issue":"10","key":"2026051211563292800_bib2","doi-asserted-by":"crossref","first-page":"e009499","DOI":"10.1136\/jitc-2024-009499","article-title":"CRLF2-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy","volume":"12","author":"Silbert","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"1","key":"2026051211563292800_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood.2023023153","article-title":"How I treat Philadelphia chromosome-like acute lymphoblastic leukemia in children, adolescents, and young adults","volume":"145","author":"Tran","year":"2025","journal-title":"Blood"},{"issue":"12","key":"2026051211563292800_bib4","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1038\/s41375-022-01714-x","article-title":"Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions","volume":"36","author":"Thastrup","year":"2022","journal-title":"Leukemia"},{"issue":"3","key":"2026051211563292800_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(08)70070-6","article-title":"Current management and challenges of malignant disease in the CNS in paediatric leukaemia","volume":"9","author":"Pui","year":"2008","journal-title":"Lancet Oncol"},{"issue":"1","key":"2026051211563292800_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10555-020-09848-z","article-title":"Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data","volume":"39","author":"Lenk","year":"2020","journal-title":"Cancer Metastasis Rev"},{"issue":"6","key":"2026051211563292800_bib7","first-page":"360","article-title":"Extramedullary manifestations in acute lymphoblastic leukemia in children: a systematic review and guideline-based approach of treatment","volume":"10","author":"Shahriari","year":"2020","journal-title":"Am J Blood Res"},{"issue":"4","key":"2026051211563292800_bib8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa2312948","article-title":"Blinatumomab for MRD-negative acute lymphoblastic leukemia in adults","volume":"391","author":"Litzow","year":"2024","journal-title":"N Engl J Med"},{"issue":"19","key":"2026051211563292800_bib9","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1182\/blood-2017-06-743252","article-title":"Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"130","author":"Tasian","year":"2017","journal-title":"Blood"},{"issue":"7","key":"2026051211563292800_bib10","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1182\/bloodadvances.2021006035","article-title":"Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy","volume":"6","author":"Holland","year":"2022","journal-title":"Blood Adv"},{"issue":"4","key":"2026051211563292800_bib11","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/j.clml.2014.01.004","article-title":"Extramedullary B lymphoblastic leukemia\/lymphoma (B-ALL\/B-LBL): a diagnostic challenge","volume":"14","author":"Geethakumari","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"2026051211563292800_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pcl.2014.09.006","article-title":"Treatment of pediatric acute lymphoblastic leukemia","volume":"62","author":"Cooper","year":"2015","journal-title":"Pediatr Clin North Am"},{"issue":"12","key":"2026051211563292800_bib13","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1080\/10428194.2025.2541024","article-title":"Extramedullary sites of disease in B-cell acute lymphoblastic leukemia: incidence, biology, and treatment","volume":"66","author":"Agrawal","year":"2025","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2026051211563292800_bib14","first-page":"39","article-title":"Isolated extramedullary relapse in acute lymphoblastic leukemia: what can we do before and after transplant?","volume":"34","author":"Riviello-Goya","year":"2020","journal-title":"Oncology (Williston Park)"},{"issue":"7","key":"2026051211563292800_bib15","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.bbmt.2017.03.023","article-title":"Isolated extramedullary relapse of acute leukemia after allogeneic stem cell transplantation: different kinetics and better prognosis than systemic relapse","volume":"23","author":"Shem-Tov","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2026051211563292800_bib16","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s00277-020-04199-9","article-title":"Incidence, risk factors and outcome of extramedullary relapse after allogeneic hematopoietic stem cell transplantation in patients with adult acute lymphoblastic leukemia","volume":"99","author":"Yu","year":"2020","journal-title":"Ann Hematol"},{"issue":"suppl 1","key":"2026051211563292800_bib17","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1182\/blood-2023-180553","article-title":"Outcomes of B-cell acute lymphoblastic leukemia patients who relapse after blinatumomab salvage therapy - a Tertiary Centre experience","volume":"142","author":"Tan","year":"2023","journal-title":"Blood"},{"issue":"3","key":"2026051211563292800_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/cncr.33967","article-title":"Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia","volume":"128","author":"Aldoss","year":"2022","journal-title":"Cancer"},{"key":"2026051211563292800_bib19","doi-asserted-by":"crossref","first-page":"1423487","DOI":"10.3389\/fimmu.2024.1423487","article-title":"Case report: sub-clinical extramedullary B-ALL in the setting of relapse following targeted therapy","volume":"15","author":"Johns","year":"2024","journal-title":"Front Immunol"},{"issue":"9","key":"2026051211563292800_bib20","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.3324\/haematol.2021.280433","article-title":"Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin","volume":"107","author":"Kayser","year":"2022","journal-title":"Haematologica"},{"key":"2026051211563292800_bib21","doi-asserted-by":"crossref","first-page":"155896","DOI":"10.1016\/j.cyto.2022.155896","article-title":"High occurrence of CRLF2 abnormalities in Mexican children with B-cell acute lymphoblastic leukemia","volume":"155","author":"Juarez-Velazquez","year":"2022","journal-title":"Cytokine"},{"issue":"8","key":"2026051211563292800_bib22","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/s41375-021-01133-4","article-title":"Increased Incidence of IKZF1 deletions and IGH-CRLF2 translocations in B-ALL of Hispanic\/Latino children-a novel health disparity","volume":"35","author":"Raca","year":"2021","journal-title":"Leukemia"},{"issue":"4","key":"2026051211563292800_bib23","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/leu.2016.375","article-title":"High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL","volume":"31","author":"Tasian","year":"2017","journal-title":"Leukemia"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/9\/3044\/2515935\/blooda_adv-2025-018480-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/9\/3044\/2515935\/blooda_adv-2025-018480-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:56:42Z","timestamp":1778601402000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/9\/3044\/566661\/CRLF2-rearrangement-and-extramedullary-disease-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,5,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018480","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,12]]},"published":{"date-parts":[[2026,4,30]]}}}